Detalhe da pesquisa
1.
Chemically defined cytokine-free expansion of human haematopoietic stem cells.
Nature
; 615(7950): 127-133, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36813966
2.
Ex vivo expansion of human hematopoietic stem cells and clinical applications.
Cancer Sci
; 115(3): 698-705, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38221718
3.
HHEX promotes myeloid transformation in cooperation with mutant ASXL1.
Blood
; 136(14): 1670-1684, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32492700
4.
Processing and MHC class II presentation of exogenous soluble antigen involving a proteasome-dependent cytosolic pathway in CD40-activated B cells.
Eur J Haematol
; 97(2): 166-74, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26561366
5.
Understanding genetic heterogeneity in gene-edited hematopoietic stem cell products.
Exp Hematol
; 129: 104133, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38036097
6.
Controlling genetic heterogeneity in gene-edited hematopoietic stem cells by single-cell expansion.
Cell Stem Cell
; 30(7): 987-1000.e8, 2023 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37385251
7.
DHODH inhibition synergizes with DNA-demethylating agents in the treatment of myelodysplastic syndromes.
Blood Adv
; 5(2): 438-450, 2021 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33496740
8.
Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumours.
Eur J Cancer
; 51(2): 146-56, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25480557